United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
367.84
+3.51 (0.96%)
Nov 21, 2024, 2:21 PM EST - Market open
United Therapeutics Revenue
United Therapeutics had revenue of $748.90M in the quarter ending September 30, 2024, with 22.89% growth. This brings the company's revenue in the last twelve months to $2.76B, up 25.04% year-over-year. In the year 2023, United Therapeutics had annual revenue of $2.33B with 20.20% growth.
Revenue (ttm)
$2.76B
Revenue Growth
+25.04%
P/S Ratio
6.05
Revenue / Employee
$2,359,760
Employees
1,168
Market Cap
16.42B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.33B | 391.20M | 20.20% |
Dec 31, 2022 | 1.94B | 250.80M | 14.88% |
Dec 31, 2021 | 1.69B | 202.20M | 13.63% |
Dec 31, 2020 | 1.48B | 34.50M | 2.38% |
Dec 31, 2019 | 1.45B | -179.00M | -11.00% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Molina Healthcare | 37.54B |
Tenet Healthcare | 20.97B |
Baxter International | 15.06B |
Viatris | 15.05B |
Quest Diagnostics | 9.54B |
ICON Public Limited Company | 8.31B |
Moderna | 5.08B |
Hologic | 3.99B |
UTHR News
- 5 days ago - United Therapeutics: Competitive Advantages At Such Cheap Multiples Scream Buy - Seeking Alpha
- 6 days ago - United Therapeutics Expands Into Organ Transplants, But Tyvaso's Legal Battles Loom - Seeking Alpha
- 6 days ago - United Therapeutics: One To Believe In Despite Competitive Threats - Seeking Alpha
- 15 days ago - United Therapeutics Corporation to Present at the UBS Global Healthcare Conference - Business Wire
- 22 days ago - United Therapeutics Corporation (UTHR) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 22 days ago - United Therapeutics Corporation Reports Third Quarter 2024 Financial Results - Business Wire
- 4 weeks ago - United Therapeutics Corporation Announces the 500th Lung Transplant Utilizing its Centralized Ex Vivo Lung Perfusion Service - Business Wire
- 4 weeks ago - United Therapeutics Corporation to Report Third Quarter 2024 Financial Results Before the Market Opens on Wednesday, October 30, 2024 - Business Wire